Jan 7, 2025, 08:37
Mateusz Sagan: Cancer vaccines are gaining momentum
Matt Sagan, Disruptive Innovations Funding and Mentoring, Co-Founder and Angel Investor, shared a post by Eric Topol, Executive Vice-President of Scripps Research on X:
“Cancer vaccines are gaining momentum
An important and interesting pathway to fight the most aggressive cancer types.”
Quoting Eric Topol’s post:
“Cancer vaccines to rev up a person’s immune response to a tumor are gaining momentum, even vs some of the most aggressive types.
One unsettled question: why does the immune system overlook a neoantigen produced by a tumour, but gets activated when it is delivered by a vaccine?
Find more information here.”
More posts featuring Matt Sagan and Eric Topol.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 7, 2025, 08:49
Jan 7, 2025, 08:37
Jan 7, 2025, 08:34
Jan 7, 2025, 04:00
Jan 6, 2025, 19:32
Jan 6, 2025, 19:23
Jan 6, 2025, 19:21
Jan 6, 2025, 19:13
Jan 6, 2025, 19:09